Anika Therapeutics, Inc.
NASDAQ:ANIK
16.33 (USD) • At close December 24, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Anika Therapeutics, Inc. |
Symbool | ANIK |
Munteenheid | USD |
Prijs | 16.33 |
Beurswaarde | 239,162,648 |
Dividendpercentage | 0% |
52-weken bereik | 15.83 - 29.12 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Dr. Cheryl Renee Blanchard Ph.D. |
Website | https://www.anikatherapeutics.com |
An error occurred while fetching data.
Over Anika Therapeutics, Inc.
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)